Avanafil Impurity 15(CAS: 330784-47-9)

CAS Number
Related Products
Other Suppliers for Avanafil Impurity 15
Basic Information
Molecular Formula
C23H26ClN7O3
Molecular Weight
483.96 g/mol
Physical State
Powder
Physical Properties
Melting Point
150-152°C
Chemical Identifiers
SMILES
COC1=C(C=C(C=C1)CNC2=NC(=NC=C2C(=O)NCC3=NC=CC=N3)N4CCCC4CO)Cl
InChIKey
WEAJZXNPAWBCOA-INIZCTEOSA-N
Database References
MDL Number
MFCD11977961
FAQ
Avanafil Impurity 15 (CAS: 330784-47-9) is a chemical compound identified as a byproduct during the synthesis of Avanafil, a PDE5 inhibitor used in pharmaceuticals. It is typically characterized by its structural similarity to Avanafil and is used in quality control and research to ensure drug purity. Its exact chemical formula and molecular structure may vary depending on the synthesis pathway.
Avanafil Impurity 15 (CAS: 330784-47-9) is primarily used in pharmaceutical research for analytical testing, drug impurity profiling, and regulatory compliance. It may also serve as a reference standard in quality control processes to identify and quantify trace impurities in Avanafil preparations, ensuring safety and efficacy in drug development.
Avanafil Impurity 15 (CAS: 330784-47-9) is not intended for human or veterinary use and should be handled with appropriate safety measures. While specific toxicity data may not be widely available, it is generally considered low risk when used in controlled laboratory settings. Always follow standard chemical safety protocols, including personal protective equipment (PPE) and proper disposal methods.
Avanafil Impurity 15 (CAS: 330784-47-9) should be stored in a cool, dry place, away from light and moisture. Keep it in a tightly sealed container to prevent contamination and degradation. Maintain storage conditions between 15-25°C (59-77°F) and avoid exposure to air or heat to ensure stability and prolong shelf life.
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures
Contact Information
Contact Person
Liu Xiaomin
ccyyapls@126.com

![(11beta)-11-[4-(Dimethylamino)phenyl]-3,20-dioxo-19-norpregna-4,9-dien-17-yl acetate](https://static.chemtradehub.com/structs/126/126784-99-4-da69.webp)


![4-[(1R)-1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole hydrochloride (1:1)](https://static.chemtradehub.com/structs/190/190000-46-5-64eb.webp)
![8-(2-Phenylethyl)-1-oxa-3,8-diazaspiro[4.5]decan-2-one](https://static.chemtradehub.com/structs/505/5053-06-5-b2e3.webp)

![(3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone](https://static.chemtradehub.com/structs/163/163222-33-1-54c2.webp)
![8-(2-Phenylethyl)-1-oxa-3,8-diazaspiro[4.5]decan-2-one hydrochloride (1:1)](https://static.chemtradehub.com/structs/505/5053-08-7-7f40.webp)

